Delivery Order SPE2DR25D3301-SPE2DR26F19LD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of INGREZZA 80 MG capsules (30-count units) under a firm fixed price contract. The award, issued on August 25, 2025, with a completion date of September 16, 2025, represents a non-set-aside, competitively awarded delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,676.11 to AmerisourceBergen Drug Corp for INGREZZA 40 mg capsules (30-count units) on October 15, 2025, with an ultimate completion date of November 5, 2025. This firm fixed-price, competitively awarded contract (without set-aside designation) represents a purchase of pharmaceutical inventory to support federal medical supply requirements. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INGREZZA 80 mg capsules (30-count units) with a ceiling value of $4,027.70. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with performance to be completed by August 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will execute this order from its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,676.12 to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 MG capsules (30-count units) under a firm fixed-price contract. The delivery order, issued on August 15, 2025, with an ultimate completion date of September 8, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of INGREZZA 40 mg capsules (30-count units) valued at $3,676.12. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 14, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used to treat tardive dyskinesia, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of INGREZZA 60 mg capsules in a quantity of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $4,267.66 under a firm fixed-price delivery order structure, with performance to be completed by December 31, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location. The delivery...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 MG Capsule in a 30-count quantity under a firm fixed-price contract with a ceiling value of $3,676.12. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of June 24, 2025. AmerisourceBergen Drug Corp will perform this work from its corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INGREZZA 40 mg capsules (30-count) with a contract value of $3,676.12 under a firm fixed-price arrangement. This award, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, represents a non-set-aside, competitively awarded order. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 mg capsules (30-count) valued at $3,874.06 under a firm fixed-price contract. The award was issued on December 10, 2025, with an ultimate completion date of January 2, 2026. This non-set-aside delivery order represents a routine pharmaceutical procurement under the company's existing contract vehicle with the Defense Logistics Agency, with performance to occur at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 capsules of INGREZZA 40 mg, a medication used to treat tardive dyskinesia in patients with schizophrenia or bipolar disorder. This firm fixed price delivery order, valued at $15,056.06, was competitively awarded without set-aside provisions and is scheduled for completion by August 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F19LDDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $11,622.18. The delivery order, issued on December 12, 2025, with an ultimate completion date of January 6, 2026, represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, performed the contract from its corporate office location. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. INGREZZA (valbenazine) is a FDA-approved medication primarily used to treat tardive dyskinesia, a movement disorder associated with long-term antipsychotic use in patients with schizophrenia and other psychiatric conditions. As a major pharmaceutical distributor supporting federal medical procurement, AmerisourceBergen fulfills critical pharmaceutical supply needs for military healthcare systems, the Defense Health Agency, and other government entities through its comprehensive DLA contract vehicle. This delivery order exemplifies the company's role in supplying specialized neurological medications and other therapeutic pharmaceuticals to support federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.6k | 12/11/25 |